Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 740

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 740
---
 |

See Notes to Condensed Consolidated Financial Statements. F-3

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(amounts in thousands except share and per share data)
(unaudited)

| ​                                                    
 ​                                                    | ​      
 Shares | ​ | Common Stock |   |         ​ | ​ | Amount |   |   |   | ​ |   | ​ | ​ | AdditionalPaid-InCapital |   |         |   | ​ | ​ | AccumulatedDeficit |   |          |   | ​ | ​ | AccumulatedOtherComprehensiveLoss |   |      |   | ​ | ​ | TotalStockholders’Equity |   |         |   | ​ |
|:-----------------------------------------------------|:-------|:--|:-------------|:--|----------:|:--|:-------|:--|:--|:--|--:|:--|:--|:--|:-------------------------|:--|--------:|:--|:--|:--|:-------------------|:--|---------:|:--|:--|:--|:----------------------------------|:--|-----:|:--|:--|:--|:-------------------------|:--|--------:|:--|:--|
| Balance at December 31, 2023                         | ​      | ​ | ​            | ​ | 4,540,059 | ​ | ​      | ​ | ​ | $ | 5 | ​ | ​ | ​ | ​                        | $ | 742,085 | ​ | ​ | ​ | ​                  | $ | -684,745 | ​ | ​ | ​ | ​                                 | $ | -260 | ​ | ​ | ​ | ​                        | $ |  57,085 | ​ | ​ |
| Stock-based compensation expense                     | ​      | ​ | ​            | ​ |         — | ​ | ​      | ​ | ​ | ​ | — | ​ | ​ | ​ | ​                        | ​ |   1,660 | ​ | ​ | ​ | ​                  | ​ |        — | ​ | ​ | ​ | ​                                 | ​ |    — | ​ | ​ | ​ | ​                        | ​ |   1,660 | ​ | ​ |
| Shares issued upon vesting of restricted stock units | ​      | ​ | ​            |